pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
371
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
MuSK-CAART
Myasthenia Gravis
$CABA
Cabaletta Bio, Inc.
0
catalysts
Phase 1
NIM-1324
Rheumatoid Arthritis
NImmune Biopharma Inc
0
catalysts
Phase 2
NS-229
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Nippon Shinyaku Co Ltd
0
catalysts
Preclinical
← prev
page 6 of 13
next →
131
Pain
89
Neurology
1
NTM-004
Pain
Neumentum Inc
0
catalysts
Preclinical
NTM-005
Pain
Neumentum Inc
0
catalysts
Phase 2
OATD-01
Pulmonary Sarcoidosis
Molecure SA
0
catalysts
Phase 2
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
$ORKA
Oruka Therapeutics, Inc.
0
catalysts
Marketed
Opzelura
Opzelura (ruxolitinib phosphate)
Hidradenitis Suppurativa
Tyrosine-protein kinase JAK1
Tyrosine-protein kinase JAK2
$INCY
INCYTE CORP
0
catalysts
Preclinical
P-BCMACD19-ALLO1
Autoimmune Disorders
Poseida Therapeutics Inc
0
catalysts
Preclinical
PB-207
Rheumatoid Arthritis
Pan-Biome Pharmaceuticals Inc
0
catalysts
Phase 2
PH-10
Xantryl
Atopic Dermatitis (Atopic Eczema)
$PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
0
catalysts
Phase 3
PHVS-416
deucrictibant
Angioedema
Pharvaris NV
0
catalysts
Phase 2
PVX-108
Peanut Allergy
Aravax Pty Ltd
0
catalysts
Phase 2
Peanut SLIT-tablet
Peanut Allergy
ALK-Abello AS
0
catalysts
Phase 3
Pollinex Quattro Grass
Pollinex
Allergic Rhino-Conjunctivitis
Allergy Therapeutics Plc
0
catalysts
Phase 2
QT-019B
Systemic Lupus Erythematosus
Hangzhou Qihan Biotechnology Co Ltd
0
catalysts
Phase 1
R-2487
Rheumatoid Arthritis
Rise Therapeutics LLC
0
catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0
catalysts
Phase 1
RG-6540
Diffuse Large B-Cell Lymphoma
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
RGI-2001
Graft Versus Host Disease (GVHD)
REGiMMUNE Ltd
0
catalysts
Preclinical
Rejuvenated Stem Cell Therapy
Bone Marrow Transplant Rejection
Hexem Bio Inc
0
catalysts
Phase 1
SAL-0119
Rheumatoid Arthritis
Shenzhen Salubris Pharmaceuticals Co Ltd
0
catalysts
Phase 1
SB-414
Atopic Dermatitis (Atopic Eczema)
$PTHS
Pelthos Therapeutics Inc.
0
catalysts
Phase 1
SBT-115301
Autoimmune Disorders
Sonoma Biotherapeutics Inc
0
catalysts
Phase 1
SCRI-CAR19v3
Systemic Lupus Erythematosus
Seattle Children's Hospital
0
catalysts
Phase 1
SER-155
Graft Versus Host Disease (GVHD)
$MCRB
Seres Therapeutics, Inc.
0
catalysts
Phase 1
SFA-002
Plaque Psoriasis (Psoriasis Vulgaris)
SFA Therapeutics Inc
0
catalysts
Preclinical
SM-06
Neuromyelitis Optica (Devic's Syndrome)
SinoMab Bioscience Ltd
0
catalysts
Phase 2
STMC-103H
Allergies
Siolta Therapeutics Inc
0
catalysts
Preclinical
STP-144G
Autoimmune Disorders
Sirnaomics Ltd
0
catalysts
